OPKO Health (OPK)
1.64
+0.03 (1.86%)
Upcoming Events
Latest Headlines
Form 10-Q/A OPKO HEALTH, INC. For: Jun 30
August 28, 2026 4:25 PM - SEC Filing
Form 10-Q/A OPKO HEALTH, INC. For: Mar 31
August 28, 2026 4:21 PM - SEC Filing
Form 8-K OPKO HEALTH, INC. For: Aug 13
August 14, 2026 4:31 PM - SEC Filing
OPKO Health raises $125M in notes backed by mazdutide royalties
August 13, 2026 9:15 AM - StreetInsider
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests
August 13, 2026 9:15 AM - Globe NewsWire
Opko Health invests $5M in Cocrystal Pharma via private placement
August 3, 2026 7:00 AM - StreetInsider
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
August 3, 2026 7:00 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Opko Health (OPK)
July 29, 2026 6:50 AM - StreetInsider
Form 4 OPKO HEALTH, INC. For: Jul 24 Filed by: Logal Adam
July 28, 2026 4:24 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jul 24 Filed by: Rubin Steven D
July 28, 2026 4:21 PM - SEC Filing
OPKO Health (OPK) Tops Q2 EPS by 7c ; Offers Guidance
July 28, 2026 12:40 AM - StreetInsider
Form 10-Q OPKO HEALTH, INC. For: Jun 30
July 27, 2026 4:12 PM - SEC Filing
Form 8-K OPKO HEALTH, INC. For: Jul 27
July 27, 2026 4:08 PM - SEC Filing
OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results
July 27, 2026 4:05 PM - Globe NewsWire
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
July 23, 2026 12:30 PM - Globe NewsWire
Form SCHEDULE 13D/A OPKO HEALTH, INC. Filed by: FROST PHILLIP MD ET AL
July 1, 2026 4:05 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: Lachman Prem A
June 22, 2026 5:38 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: MEDEL ROGER MD
June 22, 2026 5:37 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: PAGANELLI JOHN A
June 22, 2026 5:36 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: PFENNIGER RICHARD C JR
June 22, 2026 5:35 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: UPPALURI SUBBARAO V
June 22, 2026 5:33 PM - SEC Filing
Form 4 OPKO HEALTH, INC. For: Jun 18 Filed by: Yu Alice Lin-Tsing
June 22, 2026 5:32 PM - SEC Filing
Form 8-K OPKO HEALTH, INC. For: Jun 18
June 18, 2026 4:07 PM - SEC Filing
ENTERA BIO shares preclinical data for two pipeline drugs at ENDO 2026
June 16, 2026 8:33 AM - StreetInsider
OPKO Biologics presents preclinical data for acromegaly drug candidate
June 15, 2026 8:00 AM - StreetInsider
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026
June 15, 2026 8:00 AM - Globe NewsWire
Full Article List
